Home » Topics » Regulatory » Patents

Patents
RSS

Shenzhen Targetrx Biotechnology divulges BTK inhibitors

March 2, 2018

Qingdao Marine Biomedical Research Institute patents new ER stress inhibitors

March 2, 2018

Jiangsu patents novel FGFR-4 inhibitors

March 1, 2018

Sunshine Lake Pharma presents influenza A H1N1 inhibitors

March 1, 2018

Pharmascience discloses Tec family kinase inhibitors

March 1, 2018

Dompe Farmaceutici identifies novel FFAR1 agonists

March 1, 2018

FronThera US Pharmaceuticals divulges new HIF2-alpha inhibitors

March 1, 2018

Novel anti-PD-1 antibodies presented by Y-Biologics

Feb. 28, 2018

SK Chemicals and Sanofi patent vaccine compositions for streptococcal infection

Feb. 28, 2018

RWTH Aachen discloses novel ATR kinase inhibitors

Feb. 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...